1. 239 Tyrosine kinase inhibitors (TKIs) enhance response to HER2 targeted antibodies. (September 2015) Authors: Ivers, L.; Collins, D.; Canonici, A.; Gullo, G.; O'Donovan, N.; Crown, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗